Diane Stroehmann

Diane Stroehmann, MS, RAC, currently serves as the Senior Vice President of Regulatory Affairs at Viridian Therapeutics, Inc., a position held since June 2024. Prior to this role, Diane held the position of Chief at Chief from February 2021 to June 2024 and was the Vice President of Regulatory Affairs and Global Patient Safety at Ironwood Pharmaceuticals from August 2019 to June 2024. Diane's extensive experience includes serving as Chief of Staff and Vice President of Regulatory Affairs and Quality at Sienna Biopharmaceuticals, Vice President of Regulatory Affairs, Pharmacovigilance, and Research Compliance at KYTHERA Biopharmaceuticals, and Executive Director of Regulatory Affairs at Medicis Pharmaceutical Corporation. Diane began the career as a Regulatory Affairs Specialist at Organics/LaGrange Inc. and progressed through roles at Kendle International and Pharmacia in clinical research. Diane holds a BS in Biology from the University of Illinois Urbana-Champaign and an MS in Regulatory Affairs from San Diego State University.